Skip to main content

House dust-mite allergen-specific T cell subsets in allergy and asthma

NIAID - National Institute of Allergy and Infectious Diseases

open
OpenLast verified: 2026-06-18

About This Grant

PROJECT SUMMARY One third of the population suffer from allergic diseases including asthma, rhinitis, atopic dermatitis and food allergy. House-dust mite (HDM) is the most common allergen with nearly ubiquitous presence in US homes and ~30% sensitization. It is an enigma why some people develop allergy to a ubiquitous allergen such as HDM while others don’t. HDM is also the most important allergen driving sensitization and risk of allergic diseases like asthma. But, again, only some people with HDM sensitization develop asthma and/or rhinitis, for unknown reasons. In this proposal, we will explore the mechanisms and cell types that drive either natural tolerance or allergen sensitization and the development of asthma. We focus on CD4+ helper T cells (TH) because of their importance in allergy and asthma. To determine the diversity of these TH cell subsets in allergy and asthma, we performed one of the first single-cell transcriptomic studies of HDM allergen-specific TH cells. We identified of a novel subset of HDM-specific TH cells characterized by an interferon response (IFNR) gene signature (THIFNR cells), which was negatively associated with HDM sensitization. In addition, HDM- specific TH2 cells with increased expression of IL9 were increased in HDM-sensitized subjects with asthma compared to those without asthma. Based on these findings, we hypothesize that HDM-specific THIFNR cells protect against HDM-sensitization, and IL9-expressing TH2 cells in the airways, specifically tissue-resident memory T cells (TRM cells) promote the development of HDM-allergic asthma. In Aim 1, we will determine the association between HDM-specific THIFNR cells and protection against HDM sensitization. We will assess subjects enrolled in the Isle of Wight Whole Population Birth Cohort (IOWBC; n=1456). We will identify subgroups of participants (n=140) with: (i) Persistent HDM-sensitization since childhood (ii) Never HDM- sensitization since childhood, (iii) Adult-onset HDM-sensitization, and (iv) Adult-onset HDM tolerance. Using longitudinally-collected peripheral blood mononuclear cells, we will isolate HDM-specific T cells and perform single-cell transcriptome and TCR-seq analysis to enumerate the frequency, properties, persistence and clonality of HDM-specific T cell subsets including the novel THIFNR cell subpopulation, and determine their association with protection against development of HDM-sensitization at different ages and with adult-onset tolerance. In Aim 2, we will identify HDM-specific T cell subsets in the blood and airways associated with the development of asthma in subjects with HDM-sensitization. We will enroll 125 subjects with HDM-allergy from the IOWBC (n=55 with asthma, n=70 without asthma), obtain blood and airway samples longitudinally collected, and in a subgroup following HDM-allergen bronchial challenge. We will perform single-cell transcriptome and TCR-seq analysis to determine the frequency, properties, persistence and clonality of HDM- specific TH cell and TRM subsets in the blood and airways, and their association with asthma development.

Grant Summary

House dust-mite allergen-specific T cell subsets in allergy and asthma is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $537K for university, nonprofit, healthcare org. Applications are due 2031-03-31 (open). Check eligibility and apply with FindGrants.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $537K

Deadline

2031-03-31

Complexity
High
  1. 1Confirm your organization is eligible for House dust-mite allergen-specific T cell subsets in allergy and asthma from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

House dust-mite allergen-specific T cell subsets in allergy and asthma: Frequently Asked Questions

Who is eligible for the House dust-mite allergen-specific T cell subsets in allergy and asthma?

House dust-mite allergen-specific T cell subsets in allergy and asthma is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the House dust-mite allergen-specific T cell subsets in allergy and asthma provide?

House dust-mite allergen-specific T cell subsets in allergy and asthma provides up to $537K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the House dust-mite allergen-specific T cell subsets in allergy and asthma deadline?

Applications for House dust-mite allergen-specific T cell subsets in allergy and asthma are due 2031-03-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the House dust-mite allergen-specific T cell subsets in allergy and asthma?

To apply for House dust-mite allergen-specific T cell subsets in allergy and asthma, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.

Browse More Grants